Innovative pharmaceutical approaches for the management of inner ear disorders.

Abstract

The sense of hearing is essential for permitting human beings to interact with the environment, and its dysfunctions can strongly impact on the quality of life. In this context, the cochlea plays a fundamental role in the transformation of the airborne sound waves into electrical signals, which can be processed by the brain. However, several diseases and external stimuli (e.g., noise, drugs) can damage the sensorineural structures of cochlea, inducing progressive hearing dysfunctions until deafness. In clinical practice, the current pharmacological approaches to treat cochlear diseases are based on the almost exclusive use of systemic steroids. In the last decades, the efficacy of novel therapeutic molecules has been proven, taking advantage from a better comprehension of the pathological mechanisms underlying many cochlear diseases. In addition, the feasibility of intratympanic administration of drugs also permitted to overcome the pharmacokinetic limitations of the systemic drug administration, opening new frontiers in drug delivery to cochlea. Several innovative drug delivery systems, such as in situ gelling systems or nanocarriers, were designed, and their efficacy has been proven in vitro and in vivo in cochlear models. The current review aims to describe the art of state in the cochlear drug delivery, highlighting lights and shadows and discussing the most critical aspects still pending in the field.

• Authors: Umberto M Musazzi, Silvia Franzé, Francesco Cilurzo
• Journal: Drug delivery and translational research (Drug Deliv Transl Res) Vol. 8 Issue 2 Pg. 436-449 (04 2018) ISSN: 2190-3948 [Electronic] United States
• PMID: 28462501 (Publication Type: Journal Article, Review)

Topics

• Animals
• Cochlear Diseases (drug therapy)
• Drug Administration Routes
• Drug Delivery Systems
• Ear, Inner (anatomy & histology, metabolism)
• Humans